Morning Briefing
Summaries of health policy coverage from major news organizations
Humana Says Health Law, Hepatitis C Drug Costs Hurt Profit
The insurer says, however, that the increased costs were offset in part by increasing membership.
Humana Inc. said its earnings fell in the most recent quarter as the health insurer continued to feel pressure from costs related to insurance exchanges and new, expensive hepatitis C drugs. The company said these effects were offset in large part by increasing membership, although its results fell below analysts’ expectations. (Calia, 11/7)
Health insurer Humana Inc said on Friday that third-quarter profit fell as it invested in the Obamacare health insurance exchanges and state-based health contracts, and paid for costly hepatitis C treatments. (Humer, 11/7)
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
